As demand for weight-loss injections sold under brand names such as Ozempic and Wegovy continues to soar, a study has ...

T he newest weight-loss drugs, Wegovy and Zepbound, are incredibly popular. But doctors are still learning about all of the ...

Research shows that people who take these weight-loss medications may have a lower risk of dementia and numerous other health ...

Some outcomes, like reduced risk of cardiovascular disease and increased chance of nausea, were expected. But others took ...

Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...

If successful, the result could be lower Medicare Part D prices for drugs used to create a variety of conditions, such as ...

The skyrocketing popularity of weight-loss drugs like Wegovy, one of a class of drugs called GLP-1s, is fast becoming a state ...

Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

GLP-1 medications linked to a lower risk of dementia and addiction but higher risk of kidney, pancreatic, and ...

A major study involving two million people has unveiled surprising effects of weight-loss drugs like Ozempic and Wegovy.

The weight loss market is evolving at an unprecedented rate with the advancements in anti-obesity medications, and 2025 will ...

A new study uncovers how widely used weight loss drugs like Ozempic impact various health conditions while posing notable ...